Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2943-2020Class II

Talladium Luminesse Zirconia Discs, Zirconia HT Disc 98x20mm A1, Shaded Zirconia Blend 2.0 50# A1, Model No...

Talladium Inc / initiated 2020-08-06 / Terminated / root cause: labeling and UDI

Talladium Inc began a recall of Talladium Luminesse Zirconia Discs, Zirconia HT Disc 98x20mm A1, Shaded Zirconia Blend 2.0 50# A1, Model No. 5147-A1;(UDI): D7915147A10 - Product Usage: are... on . FDA classified it as Class II and gives the reason as "The linear shrinkage on the zirconia blank disc s part label is incorrect. The average linear shrinkage found on the product label was outside the acceptable range. The acceptable average linear shrinkage ranges between...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2943-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Talladium Inc
Product
Talladium Luminesse Zirconia Discs, Zirconia HT Disc 98x20mm A1, Shaded Zirconia Blend 2.0 50# A1, Model No. 5147-A1;(UDI): D7915147A10 - Product Usage: are intended for CAD/CAM fabrication of all-ceramic (no metal) dental restorations. Luminesse ZR Blanks are partially sintered Yttria stabilized zirconia blanks for use as CAD/CAM milling blanks.
Product code
EIH Powder, Porcelain
Reason for recall
The linear shrinkage on the zirconia blank disc s part label is incorrect. The average linear shrinkage found on the product label was outside the acceptable range. The acceptable average linear shrinkage ranges between 1.225 to 1.275. The production lot being recalled has a linear shrinkage rate of 2.251 which is above the acceptable range.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
The recall notification letters were sent on 08/12/2020, via FedEx Priority Overnight. The following is included in the recall notification as actions required: Immediately check your stock and quarantine the affected stock on hand to prevent further use. Using the provided customer letter and Recall Acknowledgement Form templates, communicate this recall to any of your customers who have received product included within the scope of the recall. To return product, complete the Recall Acknowledgement Form, scan and email to [email protected], Attn: Michael Capellan. This will allow to document the amount of product you have on hand for return. A customer service representative will contact you with a Return Merchandise Authorization (RMA) Number and will provide instructions for the return of product. Using the provided customer letter and Recall Acknowledgement Form templates, communicate this recall to any of your customers who have received product included within the scope of the recall. Have the customers return any affected product to you, together with a completed Recall Acknowledgement Form, for consolidation and return to the recalling firm. Please complete the attached Acknowledgement form even if you do not have any affected stock, scan and email to [email protected] or mail to 27360 W. Muirfield Lane, Valencia, CA 91355. ATTN: Michael Capellan PRODUCT RECALL. You can also report an adverse event to the FDAs MedWatch Adverse Event Reporting program: A. Online at: http://www.fda.gov/safety/medwatch/howtoreport/default.htm B. Report by telephone: 1-800-FDA-1088 or Fax report: 1-800-FDA-0178. If you have any other questions, feel free to contact Michael Capellan at [email protected].
Quantity in commerce
39 pieces
Distribution
U.S. Nationwide distribution including in the states of CA, FL, KS, LA, MO, and PA. No OUS Consignees.
Product codes and lots
Lot Number.: 1AZG

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2943-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2943-2020Class IITerminatedVoluntary: Firm initiated